Brands Use Clinical Research as Growth Engine

Supplement and cleaning brands like AG1, Ritual, and Blueland are increasingly funding their own clinical research to differentiate products, boost advertising performance, and gain retail shelf space. These companies conduct or commission studies published in peer-reviewed journals, using findings to support marketing claims and product development. For instance, AG1 committed $20 million to research, while Ritual has invested over $5 million in studies. Such research helps brands combat misinformation, appeal to data-driven consumers, and satisfy wholesale buyers demanding third-party validation. Although there is no official FTC definition of 'clinical,' companies follow guidelines requiring competent scientific evidence for health claims. This strategy serves as a long-term brand investment, with executives noting higher-performing ads and stronger retail positioning as outcomes.